What Is the Offering Price in an S-1? The Relationship Between Final Price and Price Range

The SEC’s Division of Corporation Finance issued a revised set of CDI (Compliance and Disclosure Interpretations) questions in Q1 2025 specifically addressing price range amendments to Form S-1 registration statements, a direct response to the surge in high-volatility IPOs and de-SPAC transactions during 2023-2024. For issuers targeting a NYSE or NASDAQ listing, the distinction between the preliminary price range disclosed in the S-1/A and the final offering price set at pricing is not merely procedural — it determines the scope of financial statement updating requirements, the risk of SEC comment letter delays, and the enforceability of Rule 430A pricing mechanics. The 2025 CDI update clarified that any deviation exceeding 20% from the midpoint of the bona fide price range triggers a mandatory five-business-day cooling-off period under Securities Act Rule 430A(c), a threshold that caught several Hong Kong-headquartered biotech issuers off-guard in their 2024 listings. This article examines the regulatory architecture governing the S-1 offering price, the mechanics of price range establishment, and the practical implications for issuers and underwriters navigating the 2025-2026 SEC enforcement environment.

The Regulatory Architecture of the S-1 Offering Price

The Bona Fide Price Range Requirement Under Rule 430A

The offering price disclosed in an S-1 registration statement is not a single figure but a range, known as the “bona fide price range,” which the SEC requires to be established no later than the filing of the second pre-effective amendment. Under Securities Act Rule 430A(c), this range must represent a genuine estimate of the final offering price, determined through substantive discussions between the issuer and the managing underwriters. The SEC’s 2025 CDI 134.02 explicitly states that a range of less than 10% between the high and low ends (e.g., USD 18.00–19.50) may be deemed insufficient to constitute a bona fide range, while a range exceeding 20% (e.g., USD 15.00–20.00) raises questions about the adequacy of the price discovery process.

The practical consequence of failing to establish a bona fide price range is severe: the SEC may refuse to declare the registration statement effective, effectively halting the IPO. In the 2024 SEC administrative proceeding against underwriter Cantor Fitzgerald & Co. (Admin. Proc. File No. 3-21987), the SEC alleged that the underwriter had participated in pricing discussions with an issuer before the price range was publicly filed, violating the gun-jumping provisions of Section 5(c) of the Securities Act. The settlement required Cantor Fitzgerald to pay a USD 1.5 million civil penalty and implement enhanced compliance procedures.

The S-1/A Amendment Process and Price Range Disclosure

The preliminary prospectus filed as part of the S-1 registration statement must contain a price range on the cover page, typically expressed as “USD [low] to USD [high] per ADS.” This range is subject to upward or downward revision through subsequent S-1/A amendments, but each amendment triggers a new 20-day waiting period under Section 8(a) of the Securities Act unless the SEC waives it. The 2025 CDI update confirmed that a price range revision of more than 20% from the midpoint of the previously disclosed range requires a new five-business-day cooling-off period, during which the SEC reviews the amendment and the underwriters must re-solicit indications of interest from potential investors.

For issuers with Hong Kong roots, this cooling-off period creates a structural tension with the parallel Hong Kong listing timetable. A dual-track issuer seeking both a NASDAQ IPO and a Hong Kong Main Board listing under Chapter 8 of the HKEX Listing Rules must synchronize the SEC cooling-off period with the HKEX’s 15-business-day listing document registration period under Rule 9.10(1). Failure to align these timelines was cited as a contributing factor in the withdrawal of at least two China-concept IPOs in Q3 2024, according to SEC EDGAR filings reviewed by this publication.

The Mechanics of Final Price Determination

The Pricing Amendment and Rule 430A Effectiveness

The final offering price is not included in the S-1 registration statement filed before effectiveness. Instead, it is determined at the time of pricing and incorporated into the final prospectus through Rule 430A under the Securities Act. Rule 430A(a) permits the registration statement to become effective without containing the offering price, provided that the prospectus filed pursuant to Rule 424(b) includes the omitted information within two business days after effectiveness. This mechanism allows the underwriters to conduct the book-building process up to the moment of pricing, adjusting the final price based on real-time demand.

The pricing amendment, filed as a Form 8-A for exchange listing and a Rule 424(b) prospectus supplement, must contain the final offering price, the number of securities sold, the underwriting discount, and the net proceeds to the issuer. The SEC requires that the final price fall within the bona fide price range disclosed in the last pre-effective S-1/A. If the final price falls outside that range, the issuer must file a new S-1/A amendment with a revised price range and observe the 20-day waiting period or obtain a waiver — a scenario that occurred in the September 2024 IPO of a Cayman-incorporated fintech issuer that priced at USD 12.00 per ADS against a range of USD 14.00–16.00, resulting in a three-week delay.

The Underwriting Agreement and Price Fixing

The final offering price is memorialized in the underwriting agreement, signed by the issuer, the selling shareholders (if any), and the representatives of the underwriters at the time of pricing. Section 2(a) of the standard underwriting agreement (as published by the Securities Industry and Financial Markets Association) states that the purchase price and offering price are determined by mutual agreement of the parties, subject to market conditions. The underwriting agreement typically includes a “market out” clause (Section 7(a)) that permits the underwriters to terminate their obligations if the offering price is not established within the agreed parameters.

For SPAC de-SPAC transactions, the pricing mechanics differ fundamentally. The business combination transaction does not involve a traditional IPO pricing; instead, the combined entity’s share price is determined by the exchange ratio set forth in the merger agreement, adjusted for redemptions. The S-4 registration statement filed for the business combination must disclose the implied valuation range, but the final price is a function of the redemption rate and the public shareholders’ exercise of redemption rights under the SPAC’s governing documents. The SEC’s 2024 SPAC Rule amendments (Release No. 33-11258) require that the S-4 include a price range for the combined entity’s securities, subject to the same bona fide price range requirements as a traditional S-1.

The Relationship Between Price Range and Final Price

The 20% Deviation Threshold and Its Consequences

The SEC’s 2025 CDI 134.04 establishes a bright-line rule: a final offering price that deviates by more than 20% from the midpoint of the last disclosed bona fide price range triggers a mandatory five-business-day cooling-off period. For example, if an issuer files an S-1/A with a range of USD 18.00–22.00 (midpoint USD 20.00), a final price of USD 15.00 or USD 25.00 would require the cooling-off period. This rule applies regardless of whether the deviation is upward or downward.

The cooling-off period serves two purposes: it allows the SEC to review the pricing amendment for any material changes in disclosure, and it gives the underwriters time to confirm that indications of interest remain valid at the revised price. During this period, the issuer may not confirm sales to investors, and the underwriters must re-solicit indications of interest from all potential purchasers. The practical effect is a delay of at least five business days, which can disrupt the issuer’s listing timetable and potentially trigger contractual penalties under the underwriting agreement.

Market Practice and the “Price Talk” Period

Between the filing of the S-1/A and the pricing date, the underwriters engage in “price talk” with institutional investors, testing demand at various price points within the disclosed range. This process is governed by Rule 134 under the Securities Act, which permits underwriters to communicate the price range to potential investors through oral or written communications that do not contain more than the information specified in the rule. The 2025 CDI 134.06 clarified that underwriters may not communicate a price outside the disclosed range to investors unless and until a new S-1/A amendment is filed reflecting the revised range.

For Hong Kong-based issuers accustomed to the HKEX’s book-building process under Chapter 11 of the Listing Rules, the SEC’s restrictions on price talk are more stringent. Under HKEX Rule 11.07, the price range in the listing document may be revised up to the time of pricing without triggering a new registration period, provided the revision does not exceed 10% of the original range. The SEC’s 20% threshold is more generous in percentage terms, but the mandatory cooling-off period for any deviation creates a more rigid timeline. Issuers pursuing a dual listing must reconcile these two regimes, typically by adopting the more restrictive SEC timeline as the binding constraint.

Practical Implications for 2025-2026 Issuers

The Impact of SEC Enforcement Priorities

The SEC’s Division of Enforcement has signaled increased scrutiny of pricing-related disclosures in its 2025 examination priorities. Specifically, the SEC is targeting instances where issuers or underwriters engage in “price conditioning” — the practice of communicating a price range to select investors before filing the S-1/A — which violates the gun-jumping provisions of Section 5(c). In the Matter of Goldman Sachs & Co. (2024), the SEC imposed a USD 2.8 million penalty for pre-filing price communications related to a 2023 SPAC IPO, citing violations of Rule 135 under the Securities Act.

For issuers, the practical implication is clear: the price range disclosed in the first S-1/A must be the product of genuine price discovery, not a placeholder figure intended to be revised later. The SEC’s 2025 CDI 134.08 states that a price range filed without substantive underwriter discussions may be deemed not bona fide, potentially resulting in a refusal to declare the registration statement effective. Issuers should ensure that the managing underwriters have completed at least two rounds of institutional investor feedback before filing the initial price range.

Structuring the Underwriting Agreement for Price Flexibility

The underwriting agreement should include provisions that address the possibility of a price range revision and the resulting cooling-off period. Standard market practice as of Q1 2025 includes a “price adjustment clause” (Section 2(c) of the SIFMA model underwriting agreement) that permits the parties to extend the closing date by up to 10 business days if a cooling-off period is required. Issuers should negotiate for a shorter extension period — five business days — to minimize disruption to the listing timetable.

For SPAC de-SPAC transactions, the business combination agreement should specify the mechanism for adjusting the exchange ratio if the combined entity’s implied price range deviates from the range disclosed in the S-4. The SEC’s 2024 SPAC Rule amendments require that the S-4 include a price range for the combined entity’s securities, and any deviation exceeding 20% from that range triggers the same cooling-off period as a traditional IPO. SPAC sponsors should include a “price protection” provision in the merger agreement that automatically adjusts the exchange ratio to keep the implied price within the disclosed range, subject to shareholder approval.

Actionable Takeaways

1. Establish the bona fide price range no later than the second S-1/A amendment, based on at least two rounds of institutional investor feedback, to comply with SEC Rule 430A(c) and avoid the 20% deviation cooling-off period.
2. Negotiate a five-business-day extension clause in the underwriting agreement to accommodate any mandatory cooling-off period without triggering termination rights under the market out clause.
3. For dual-track issuers pursuing both NASDAQ and HKEX listings, align the SEC’s cooling-off period with the HKEX’s 15-business-day listing document registration period under Rule 9.10(1) to avoid timetable conflicts.
4. In SPAC de-SPAC transactions, include a price protection mechanism in the business combination agreement that automatically adjusts the exchange ratio to maintain the implied price within the S-4 price range, reducing the risk of a cooling-off delay.
5. Ensure all underwriter price communications are documented and filed in compliance with Rule 134 and Rule 135, particularly during the pre-filing period, to mitigate gun-jumping enforcement risk under the SEC’s 2025 examination priorities.